DK52875A - - Google Patents

Info

Publication number
DK52875A
DK52875A DK52875*#A DK52875A DK52875A DK 52875 A DK52875 A DK 52875A DK 52875 A DK52875 A DK 52875A DK 52875 A DK52875 A DK 52875A
Authority
DK
Denmark
Application number
DK52875*#A
Other versions
DK143247C (da
DK143247B (da
Inventor
A J Torode
D Harden
J Spence
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK52875(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK52875A publication Critical patent/DK52875A/da
Publication of DK143247B publication Critical patent/DK143247B/da
Application granted granted Critical
Publication of DK143247C publication Critical patent/DK143247C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK52875A 1974-02-14 1975-02-13 Medicinsk tablet indeholdende som aktiv bestanddel en 2,4-diamino-5-benzylpyrimidin sammen med et sulfonamid DK143247C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB675874 1974-02-14
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (3)

Publication Number Publication Date
DK52875A true DK52875A (da) 1975-10-06
DK143247B DK143247B (da) 1981-08-03
DK143247C DK143247C (da) 1981-11-30

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
DK52875A DK143247C (da) 1974-02-14 1975-02-13 Medicinsk tablet indeholdende som aktiv bestanddel en 2,4-diamino-5-benzylpyrimidin sammen med et sulfonamid

Country Status (32)

Country Link
JP (1) JPS5545043B2 (da)
AT (1) AT344915B (da)
AU (1) AU468465B2 (da)
BE (1) BE825496A (da)
CA (1) CA980688A (da)
CH (1) CH618432A5 (da)
CS (1) CS220306B2 (da)
CY (1) CY1052A (da)
DD (1) DD118228A5 (da)
DE (1) DE2506099C2 (da)
DK (1) DK143247C (da)
DO (1) DOP1979002763A (da)
ES (1) ES434688A1 (da)
FI (1) FI62219C (da)
FR (1) FR2260993B1 (da)
GB (1) GB1499672A (da)
GT (1) GT197960431A (da)
HK (1) HK23980A (da)
HU (1) HU171536B (da)
IE (1) IE40599B1 (da)
IL (1) IL46629A (da)
IN (1) IN141019B (da)
KE (1) KE3038A (da)
LU (1) LU71835A1 (da)
MC (1) MC1053A1 (da)
MY (1) MY8100054A (da)
NL (1) NL157501C (da)
NO (1) NO146043C (da)
PH (1) PH14575A (da)
SE (1) SE427898B (da)
ZA (1) ZA75930B (da)
ZM (1) ZM1875A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
ATA108475A (de) 1977-12-15
GB1499672A (en) 1978-02-01
AT344915B (de) 1978-08-25
FR2260993A1 (da) 1975-09-12
FI750398A (da) 1975-08-15
GT197960431A (es) 1981-05-05
PH14575A (en) 1981-09-24
SE427898B (sv) 1983-05-24
CA980688A (en) 1975-12-30
DD118228A5 (da) 1976-02-20
IL46629A (en) 1977-07-31
IN141019B (da) 1977-01-08
NL157501C (nl) 1981-07-16
NO750467L (da) 1975-08-15
DK143247C (da) 1981-11-30
CH618432A5 (en) 1980-07-31
DOP1979002763A (es) 1987-06-18
CS220306B2 (en) 1983-03-25
FI62219B (fi) 1982-08-31
CY1052A (en) 1980-08-01
AU7817075A (en) 1976-01-15
FI62219C (fi) 1982-12-10
LU71835A1 (da) 1975-06-24
NL157501B (nl) 1978-08-15
FR2260993B1 (da) 1978-06-30
IL46629A0 (en) 1975-05-22
IE40599L (en) 1975-08-14
IE40599B1 (en) 1979-07-04
NO146043C (no) 1982-08-04
DE2506099A1 (de) 1975-08-21
ES434688A1 (es) 1977-04-01
JPS5545043B2 (da) 1980-11-15
DK143247B (da) 1981-08-03
HK23980A (en) 1980-05-09
ZA75930B (en) 1976-01-28
MY8100054A (en) 1981-12-31
HU171536B (hu) 1978-01-28
NL7501680A (nl) 1975-08-18
KE3038A (en) 1980-04-25
MC1053A1 (fr) 1976-02-20
AU468465B2 (en) 1976-01-15
BE825496A (fr) 1975-05-29
DE2506099C2 (de) 1983-11-03
NO146043B (no) 1982-04-13
ZM1875A1 (en) 1975-12-22
SE7501595L (da) 1975-08-15
JPS50116627A (da) 1975-09-12

Similar Documents

Publication Publication Date Title
FR2265872B1 (da)
JPS5545043B2 (da)
BG19713A1 (da)
BG19746A1 (da)
BG20244A1 (da)
BG20501A1 (da)
BG20746A1 (da)
BG20884A1 (da)
BG21136A2 (da)
BG21312A1 (da)
BG21623A1 (da)
BG21710A1 (da)
BG22303A1 (da)
BG22518A1 (da)
CH1340175A4 (da)
CH1446574A4 (da)
CH231275A4 (da)
CH238674A4 (da)
CH563833A5 (da)
CH566532A5 (da)
CH569333A5 (da)
CH570549A5 (da)
CH571710A5 (da)
CH572263A5 (da)
CH572577A5 (da)

Legal Events

Date Code Title Description
PUP Patent expired